Industry exhibition
The industry exhibition will take place together with the poster exhibition. It will give you a wide overview over the latest achievements concerning Inflammatory Bowel Diseases as well as state-of-the-art technical equipment. Exhibitors will display the most recent publications in the field of Inflammatory Bowel Diseases and related sciences. For all enquiries regarding the industry exhibition and sponsorship opportunities please contact the ECCO Office.
Exhibitors at the 10th Congress of ECCO:
Please note that the location of the following exhibition booths changed:
Sanquin Reagents - Booth number 037
Wisepress - Booth number 029
| Exhibitor name | Booth number |
| AbbVie | 014 |
| AbbVie | 017 |
| Bühlmann Labs | 018 |
| Calpro | 010 |
| Celltrion | 015 |
| Covidien | 031 |
| DiaSorin | 022 |
| Dr. Falk Pharma | 002 |
| Edimark - La lettre de l'Hépato-Gastroentérologue | 032 |
| EFCCA - European Federation of Crohn's and Colitis Associations | 028 |
| Eurospital | 007 |
| Ferring | 016 |
| GE Healthcare | 006 |
| Genetic Analysis AS | 011 |
| Grifols | 030 |
| Hospira | 021 |
| Immundiagnostik | 027 |
| Membrana GmbH | 035 |
| MDT Int'l SA | 033 |
| Mendes S.A. | 008 |
| MSD | 001 |
| Nikkiso | 005 |
| Orgentec Diagnostik GmbH | 026 |
| Origin Sciences | 025 |
| Otsuka | 003 |
| Pharmacosmos | 012 |
| Robarts Clinical Trials | 024 |
| Roche | 034 |
| Sanquin Reagents | 037 |
| Sephure | 009 |
| Shire | 013 |
| Takeda | 004 |
| Thermo Fisher Scientific | 023 |
| Tillotts Pharma | 019 |
| Vifor Pharma | 020 |
| Wisepress | 029 |
Industry and poster exhibition hours:
Setup
|
Tuesday, February 17, 2015 |
07:30-22:00 |
| Wednesday, February 18, 2015 | 07:30-22:00 |
| Thursday, February 19, 2015 | 07:30-10:00 |
Exhibition
| Thursday, February 19, 2015 | 12:00-18:00 |
| Friday, February 20, 2015 | 09:30-18:00 |
| Saturday, February 21, 2015 | 09:30-13:15 |
Dismantling
| Saturday, February 21, 2015 | 13:15-22:00 |
CCIB_Photo_Brochure_2015.pdf561.94 KB
CCIB_General_Regulations_EXPO_2015.pdf160.68 KB
